FDA NDC
CombiPatch (estradiol/norethindrone acetate transdermal system)
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 68968-0514
- Proprietary name
- CombiPatch (estradiol/norethindrone acetate transdermal system)
- Nonproprietary name
- estradiol/norethindrone acetate transdermal system
- Labeler
- Noven Therapeutics, LLC
- Dosage form
- PATCH, EXTENDED RELEASE
- Strength
- .05 mg/d
Run it in Rivvi
Which 2027 plans near you dropped or restricted estradiol/norethindrone acetate transdermal system?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.